Validation of proposals for definitions of moderate and severe disease activity in SLE: impact on flares, quality of life, damage accrual, hospitalisations and mortality.
Altabás-González I, Rua-Figueroa I, Roberts K, Mamani IL, Mouriño C, Martinez-Barrio J, Galindo Izquierdo M, Calvo-Alén J, Erausquin C, Serrano-Benavente B, Uriarte E, Tomero E, Freire-González M, Blanco R, Salgado E, Gómez-Sabater S, Fernandez-Nebro A, Sangüesa C, Narvaez J, Mena Vázquez N, Menor-Almagro R, Rosas Gómez de Salazar JC, Aurrecoechea E, Ibarguengoitia-Barrena O, Montilla C, Bonilla G, Segarra VT, Juan-Mas A, García-Villanueva MJ, Morales CM, Horcada L, Lozano-Rivas N, Iñiguez C, Arevalo M, Paredes B, Exposito L, Toyos FJ, Flores-Fernandez E, Nóvoa Medina J, Fragio Gil JJ, Bohórquez C, Pego-Reigosa JM.
Altabás-González I, et al. Among authors: blanco r.
Lupus Sci Med. 2025 Dec 23;12(2):e001766. doi: 10.1136/lupus-2025-001766.
Lupus Sci Med. 2025.
PMID: 41436237
Free PMC article.